Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

A woman's scalp condition improved with specific ointment after a hair piece caused skin issues.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.